This dense packing serves to repress or "silence" the DNA sequences within—which could wreck the genome if activated—as well as regulate the activity of nearby genes. When the cell divides, the daughter cells not only inherit a copy of the mother cell's DNA, but also the exact pattern in which that DNA is clumped into heterochromatin.
This "epigenetic" mode of inheritance—information not transmitted through the DNA code itself but by the way in which it is packaged—has long been investigated by Cold Spring Harbor Laboratory Professor and HHMI-GBMF Investigator Rob Martienssen. In a landmark study that was hailed as one of the breakthroughs of the year by Science magazine in 2002, Martienssen and his colleagues showed that the inheritance of heterochromatin depends on a set of mechanisms broadly defined as RNA interference (RNAi).
In a new study that appears online in Nature on October 16, Martienssen's team, including investigators from the Pasteur Institut in Paris and the University of Salamanca in Spain, describes a new role for RNAi, one that allows the DNA replication process itself to progress smoothly without resulting in DNA damage.
DNA is normally coiled around proteins called histones, which when chemically modified at specific locations, aggregate into dense arrays to form heterochromatin. Martienssen and others had previously found that RNAi guides this histone modification process, which occurs at the same time in the cell cycle when DNA is being duplicated.
In this RNAi-guided process, an enzyme called polymerase II copies or "transcribes" specific regions of DNA into RNA molecules, and somehow this modifies histones in those exact regions, thereby creating heterochromatin. These heterochromatic regions, however, alternate with so-called "origins of replication" – spots on the DNA where DNA-building proteins can bind, unzip the double-stranded DNA molecule to create a replication "fork," and begin to build a new strand of it.
This alternate arrangement of regions to be transcribed for heterochromatin assembly and regions that serve as origins for DNA replication raised a new question: how do the transcription machinery and the replication machinery work in tandem without colliding with each other and as a result stall the replication fork and trigger DNA damage?
In a recent study, Martienssen collaborated with scientists at the University of California at Berkeley and showed that the DNA-building proteins themselves could latch on to histone-modifying proteins and pull them along the replication fork.
"This finding raised the question of what role RNAi actually plays during the replication phase of the cell cycle," says Martienssen. "The answers to both questions turned out to be very simple and elegant."
His group's experiments in fission yeast, a simple model system used for studying heterochromatin, show that when the polymerase II enzyme has transcribed a stretch of DNA into RNA, the RNAi mechanism causes the enzyme to release its hold on the DNA and fall away. This allows the replication fork to progress smoothly and the DNA strands to be copied by the replication machinery. The histone-modifying proteins, which follow right along, establish heterochromatin.
The scientists found that failure or absence of the RNAi mechanism stalls replication, which triggers a strong "DNA damage" alert within the cell. That's when a repair mechanism called homologous recombination kicks in and repairs the stalled fork, but the ability to modify histones is lost.
"These experiments have revealed the real role of RNAi during the cell's replication phase, which is to protect cells from this sort of replication-associated fork damage," according to Martienssen.
"RNAi promotes heterochromatic silencing through replication-coupled release of RNA Pol II" appears online in Nature on October 16. The full citation is: Mikel Zaratiegui, Stephane Castel1, Danielle V. Irvine, Anna Kloc, Jie Ren, Fei Li, Elisa de Castro, Laura Marý´n, An-Yun Chang, Derek Goto, W. Zacheus Cande, Francisco Antequera, Benoit Arcangioli & Robert A. Martienssen. The paper can be downloaded at http://dx.doi.org/ using the doi 10.1038/nature10501.
About Cold Spring Harbor Laboratory
Founded in 1890, Cold Spring Harbor Laboratory (CSHL) has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. CSHL is ranked number one in the world by Thomson Reuters for impact of its research in molecular biology and genetics. The Laboratory has been home to eight Nobel Prize winners. Today, CSHL's multidisciplinary scientific community is more than 350 scientists strong and its Meetings & Courses program hosts more than 11,000 scientists from around the world each year. Tens of thousands more benefit from the research, reviews, and ideas published in journals and books distributed internationally by CSHL Press. The Laboratory's education arm also includes a graduate school and programs for undergraduates as well as middle and high school students and teachers. CSHL is a private, not-for-profit institution on the north shore of Long Island. For more information, visit www.cshl.edu.
Hema Bashyam | EurekAlert!
Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland
Protein involved in nematode stress response identified
14.12.2018 | University of Illinois College of Agricultural, Consumer and Environmental Sciences
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy